Idiopathic thromboembolism as the presenting sign of occult prostate cancer

Urology

Volumn 51, Issue 5, 1998, Pages 775-780

  Oefelein, Michael G ^a   Brant, Michael ^a   Crotty, Karen ^a  

^a WRIGHT PATTERSON AIR FORCE BASE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; SCORING SYSTEM; THROMBOEMBOLISM;

AGED; CASE-CONTROL STUDIES; COHORT STUDIES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; ODDS RATIO; PARANEOPLASTIC SYNDROMES; PHYSICAL EXAMINATION; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PULMONARY EMBOLISM; RECTUM; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM; THROMBOPHLEBITIS;

EID: 0031798738     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00008-9     Document Type: Article

References (13)

1. Rickles FR, Edwards RL. Activation of blood coagulation in cancer Trousseau's syndrome revisited . Blood. 62:1983;14-31.
2. Wright IS. The pathogenesis and treatment of thrombosis. Circulation. 5:1952;161-188.
3. Ackerman FR, Estes E. Prognosis in idiopathic thrombophlebitis. Ann Intern Med. 34:1951;902-910.
4. Gore MJ, Appelbaum SJ, Greene LH, Dexter L, Dalen EJ. Occult cancer in patients with acute pulmonary embolism. Ann Intern Med. 96:1982;556-560.
5. Cornuz J, Pearson SD, Creager MA, Cook EF, Goldman L. Importance of findings on the initial evaluation for cancer in patients with symptomatic idiopathic deep venous thrombosis. Ann Intern Med. 125:1996;785-793.
6. Prandoni P, Lensing AWA, Buller HR, Cogo A, Prins MH, Cattelan AM, Cuppini S, Noventa F, Ten Cate JW. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med. 327:1992;1128-1133.
7. Goldberg RJ, Seneff M, Gore JM, Anderson FA, Greene HL, Wheeler B, Dalen JE. Occult malignant neoplasm in patients with deep venous thrombosis. Arch Intern Med. 147:1987;251-253.
8. Monreal M, Lafoz E, Casals A, Inaraja L, Montserrat E, Callejas JM, et al. Occult cancer in patients with deep venous thrombosis a systemic approach . Cancer. 67:1991;541-545.
9. Nordstrom M, Lindbland B, Anderson H, Bergqvist D, Kjellstrom T. Deep venous thrombosis and occult malignancy an epidemiological study . Br Med J. 308:1994;891-894.
10. Aderka D, Brown A, Zelikovski A, Pinkhas J. Idiopathic deep vein thrombosis in an apparently healthy patient as a premonitory sign of occult cancer. Cancer. 57:1986;1846-1849.
11. Griffin MR, Stanson AW, Brown ML, Hauser MF, O'Fallon WM, Anderson HM, Kazmier FJ, Melton LJ. Deep venous thrombosis and pulmonary embolism - risk of subsequent malignant neoplasms. Arch Intern Med. 147:1987;1907-1911.
12. Anlyan WG, Shingloton WW, DeLaughter GD Jr. Significance of idiopathic venous thrombosis and hidden cancer. JAMA. 161:1956;964-966.
13. Berges RR, Vulkanovic J, Epstein JI, CarMichel M, Cisek L, Johnson DE, Veltri RW, Walsh PC, Isaacs JT. Implications of cell kinetic changes during the progression of human prostate cancer. Clin Cancer Res. 1:1995;473-476.